triamcinolone acetonide + ketorolac + ropivacaine

A multimodal drug combination used primarily for intra-articular injection to manage post-operative pain, particularly following shoulder arthroscopy. The combination leverages the anti-inflammatory properties of triamcinolone acetonide (a corticosteroid), the analgesic effects of ketorolac (an NSAID), and the local anesthetic properties of ropivacaine. According to the search results, this combination has been studied for its efficacy in providing post-surgical pain relief. Research has shown that combining ketorolac with triamcinolone acetonide and ropivacaine (along with morphine in some formulations) produces more effective pain relief during the first 48 hours after surgery compared to regimens without ketorolac[2]. ## Composition and Mechanism The combination typically consists of: 1. **Triamcinolone acetonide** - A synthetic corticosteroid that reduces inflammation through multiple pathways 2. **Ketorolac tromethamine** - A non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis 3. **Ropivacaine** - A local anesthetic that blocks nerve impulses Studies have confirmed that mixing these medications does not result in extreme pH changes or precipitation, making it safe for combined administration[1]. ## Clinical Applications The primary use of this combination is for: - Post-operative pain management, particularly after shoulder arthroscopy[2] - Intra-articular injection for joint pain, including knee osteoarthritis[3] In clinical trials, patients receiving this combination showed: - Improved pain scores - Reduced morphine consumption - Prolonged time before requiring additional analgesia[2] ## Dosage Based on the search results, a typical formulation for intra-articular injection following shoulder arthroscopy might contain: - 450 mg of ropivacaine - 25 mg of triamcinolone acetonide - 10 mg of ketorolac[2] For knee osteoarthritis, different formulations are being studied, including combinations with specific dosages of each component[3].